Document is current
Any future updates will be listed below
-
Authors
Eren, Ozan E.
Gaul, Charly
Peikert, Andreas
Gendolla, Astrid
Ruscheweyh, Ruth
Straube, Andreas
- License Information
-
More Information
Article History
Received: 26 December 2019
Accepted: 18 June 2020
First Online: 9 July 2020
Competing interests
: OE. Eren has received honoraria for consulting within the past three years from Novartis Pharma. C. Gaul has received honoraria for consulting and lectures within the past three years from Allergan Pharma, Boehringer Ingelheim Pharma, Cerbotec, Desitin Arzneimittel, Grünenthal, Hormosan Pharma, Lilly Germany, Novartis Pharma, Ratiopharm, Reckitt Benckiser, Sanofi Aventis and TEVA. A. Gendolla has received honoraria for consulting and lectures within the past three years from Allergan Pharma, Bayer, GAF, Grünenthal, Lilly, Mundipharma, Novartis Pharma, Reckitt Benckiser, St. Jude Medical, TEVA, Zahnärztekammer KVNO. A. Peikert has received honoraria for consulting and lectures from Lilly, Novartis Pharma and TEVA within the past three years. R. Ruscheweyh has received honoraria for consulting and lectures within the past three years from Allergan Pharma, Hormosan, Novartis Pharma, Lilly, and TEVA. A. Straube has received honoraria for consulting and lectures within the past three years from Allergan Pharma, Bayer, Lilly, Novartis Pharma and TEVA.
